Financial News
Mainz Biomed N.V. - Ordinary Shares (NQ: MYNZ )
0.3769
+0.0279
(+7.99%)
Streaming Delayed Price
Updated: 12:45 PM EDT, Jul 22, 2024
Add to My Watchlist
Press Releases about Mainz Biomed N.V. - Ordinary Shares
![](https://ml-eu.globenewswire.com/media/44191aa8-7a57-420d-8401-8737e50a27da/small/mainz-biomed-logo-pantone-4x-100-jpg.jpg)
![](https://ml-eu.globenewswire.com/media/44191aa8-7a57-420d-8401-8737e50a27da/small/mainz-biomed-logo-pantone-4x-100-jpg.jpg)
![](https://ml-eu.globenewswire.com/media/44191aa8-7a57-420d-8401-8737e50a27da/small/mainz-biomed-logo-pantone-4x-100-jpg.jpg)
Mainz Biomed Provides Full Year 2022 Financial Results
April 10, 2023
From Mainz BioMed NV
Via GlobeNewswire
![](https://ml-eu.globenewswire.com/media/44191aa8-7a57-420d-8401-8737e50a27da/small/mainz-biomed-logo-pantone-4x-100-jpg.jpg)
![](https://ml-eu.globenewswire.com/media/44191aa8-7a57-420d-8401-8737e50a27da/small/mainz-biomed-logo-pantone-4x-100-jpg.jpg)
![](https://ml-eu.globenewswire.com/media/44191aa8-7a57-420d-8401-8737e50a27da/small/mainz-biomed-logo-pantone-4x-100-jpg.jpg)
![](https://ml-eu.globenewswire.com/media/44191aa8-7a57-420d-8401-8737e50a27da/small/mainz-biomed-logo-pantone-4x-100-jpg.jpg)
From Mainz BioMed NV
Via GlobeNewswire
![](https://ml-eu.globenewswire.com/media/44191aa8-7a57-420d-8401-8737e50a27da/small/mainz-biomed-logo-pantone-4x-100-jpg.jpg)
![](https://ml-eu.globenewswire.com/media/44191aa8-7a57-420d-8401-8737e50a27da/small/mainz-biomed-logo-pantone-4x-100-jpg.jpg)
![](https://ml-eu.globenewswire.com/media/44191aa8-7a57-420d-8401-8737e50a27da/small/mainz-biomed-logo-pantone-4x-100-jpg.jpg)
![](https://ml-eu.globenewswire.com/media/44191aa8-7a57-420d-8401-8737e50a27da/small/mainz-biomed-logo-pantone-4x-100-jpg.jpg)
![](https://ml-eu.globenewswire.com/media/44191aa8-7a57-420d-8401-8737e50a27da/small/mainz-biomed-logo-pantone-4x-100-jpg.jpg)
![](https://ml-eu.globenewswire.com/media/44191aa8-7a57-420d-8401-8737e50a27da/small/mainz-biomed-logo-pantone-4x-100-jpg.jpg)
![](https://ml-eu.globenewswire.com/media/44191aa8-7a57-420d-8401-8737e50a27da/small/mainz-biomed-logo-pantone-4x-100-jpg.jpg)
Mainz Biomed Provides Year-End 2022 Corporate Review
January 03, 2023
From Mainz BioMed NV
Via GlobeNewswire
![](https://ml-eu.globenewswire.com/media/44191aa8-7a57-420d-8401-8737e50a27da/small/mainz-biomed-logo-pantone-4x-100-jpg.jpg)
![](https://ml-eu.globenewswire.com/media/44191aa8-7a57-420d-8401-8737e50a27da/small/mainz-biomed-logo-pantone-4x-100-jpg.jpg)
Mainz Biomed Announces IRB Approval and Initiation of US Pivotal FDA Clinical Study
December 06, 2022
From Mainz BioMed NV
Via GlobeNewswire
![](https://ml-eu.globenewswire.com/media/44191aa8-7a57-420d-8401-8737e50a27da/small/mainz-biomed-logo-pantone-4x-100-jpg.jpg)
![](https://ml-eu.globenewswire.com/media/44191aa8-7a57-420d-8401-8737e50a27da/small/mainz-biomed-logo-pantone-4x-100-jpg.jpg)
![](https://ml-eu.globenewswire.com/media/44191aa8-7a57-420d-8401-8737e50a27da/small/mainz-biomed-logo-pantone-4x-100-jpg.jpg)
![](https://ml-eu.globenewswire.com/media/44191aa8-7a57-420d-8401-8737e50a27da/small/mainz-biomed-logo-pantone-4x-100-jpg.jpg)
Mainz Biomed Provides Third Quarter 2022 Update
November 02, 2022
From Mainz BioMed NV
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.